Now that the new European Commission has been appointed, it is as if the traffic lights have moved from red to amber. Appointments have been made, and although many decisions have yet to be formally taken before the lights turn green to move forward again, the shape of the future agenda for medical devices is becoming clearer, and to some extent, maybe, also the direction that is likely to take...
Scrip Regulatory Affairs
EU medtech discussions on the move again
19 March 2010
Amanda Maxwell
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
